Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04804137 · ClinicalTrials.gov registry record

Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study

A clinical trial of Metastatic Lung Cancer and Non-squamous Lung Cancer, sponsored by University Hospital, Tours.

Completed
Registry status
24
Enrollment target
2
Study locations

NCT04804137 is a study of Metastatic Lung Cancer and Non-squamous Lung Cancer that has completed, run by University Hospital, Tours. The registered enrollment target is 24 participants, below the 173-participant average among 10 other Metastatic Lung Cancer trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04804137, a study of Metastatic Lung Cancer and Non-squamous Lung Cancer, has completed, sponsored by University Hospital, Tours.

COMPLETED
Registry status
24 participants
Enrollment target
2
Study locations

Study Summary

Prospective pathophysiological exploratory monocentric study, focusing on adult patients with non-small cell lung cancer (NSCLC) : non-squamous type without oncogenic addiction, metastatic, treated with immune checkpoint inhibitors alone or in combination with chemotherapy in front line at the CHRU de Tours, France.

Conditions Studied

Metastatic Lung Cancer Non-squamous Lung Cancer

Interventions

  • OTHER Blood
  • OTHER sputum
  • OTHER saliva
  • OTHER stool

Study Locations (2)

California

  • Ferreira Marion - Los Angeles

Other

  • University hospital - Tours

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-05-03
Est. Completion 2023-07-31

Sponsor

University Hospital, Tours

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04804137

The ClinicalTrials.gov registry entry for NCT04804137 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 173-participant average among 10 other Metastatic Lung Cancer trials with a reported enrollment target (86% lower). The listed sponsor is University Hospital, Tours, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Metastatic Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Blood is the first listed.

NCT04804137 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Other.

Frequently Asked Questions

What is clinical trial NCT04804137 about?

NCT04804137 is a clinical study titled "Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study". Prospective pathophysiological exploratory monocentric study, focusing on adult patients with non-small cell lung cancer (NSCLC) : non-squamous type without oncogenic addiction, metastatic, treated with immune checkpoint inhibitors alone or in combination with chemotherapy in front line at the CHRU ...

What is the current status of trial NCT04804137?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2021-05-03. Estimated completion is 2023-07-31.

What conditions does trial NCT04804137 study?

This clinical trial studies the following conditions: Metastatic Lung Cancer, Non-squamous Lung Cancer.

What interventions are being tested in trial NCT04804137?

The interventions under investigation include: Blood (OTHER), sputum (OTHER), saliva (OTHER), stool (OTHER).

Who is sponsoring clinical trial NCT04804137?

This trial is sponsored by University Hospital, Tours, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04804137 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Metastatic Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Metastatic Lung Cancer

All registered trials for this condition

Non-squamous Lung Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.